ClinicalTrials.gg
CompletedNCT05191654Updated Jan 13, 2022

Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD

An observational study in Congenital Heart Defects, Down Syndrome and Gross Motor Development Delay, sponsored by Atılım University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Months to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by Atılım University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
28
Ages
6 Months to 5 Years
Sex
All
01

Study summary

Congenital heart diseases (CHD) are detected in 40-60% of individuals with Down syndrome (DS) and increase the risk of developmental delay in the presence of syndromes. The aim of the study was to compare cardiopulmonary parameters, gross motor development and hand grip strength in DS children with and without CHD. Demographic variables, cardiopulmonary parameters and echocardiographic values were recorded. Gross motor development was evaluated with Gross Motor Function Measure (GMFM-88). Hand grip strength was measured with the Baseline Pneumatic Bulb Dynamometer.

02

Conditions studied

  • Congenital Heart Defects
  • Down Syndrome
  • Gross Motor Development Delay

Keywords

  • congenital heart defects
  • Down syndrome
  • motor skills
03

In context

Heart Defects, Congenital

1,031 studies on the registry are indexed under Heart Defects, Congenital; 262 are open to participants now.

This study's enrollment of 28 is below the median of 120 across 459 observational studies indexed under Heart Defects, Congenital.

Browse Heart Defects, Congenital studies →

Lead sponsor

Atılım University is the lead sponsor of 36 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Children with down syndrome

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with Down syndrome as a result of genetic analysis,
  • For the congenital heart disease group; undergoing cardiac surgery at least 6 months before the evaluation, diagnosed as CHD by a pediatric cardiologist based on echocardiographic findings,
  • For the group without congenital heart disease, patients who have not undergone cardiac surgery, are asymptomatic with a septal defect smaller than 4-5 mm, are expected to close, and are hemodynamically normal by a pediatric cardiologist,
  • Children whose families were informed about the study and gave written consent to participate in the study were included in the study.

Exclusion criteria

Exclusion Criteria:

  • Having another genetic abnormality other than Down syndrome,
  • undergoing surgery other than cardiac surgery,
  • Having an orthopedic or neurological problem,
  • Respiratory support,
  • With atlantoaxial instability,
  • Children with hematological disease were not included in the study.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
28 participants (actual)
Patient registry
No

Groups and cohorts

  • with Congenital heart diseases

    Diagnostic Test: evaluation of cardiopulmonary parameters, gross motor development and hand grip strength

  • without Congenital heart diseases

    Diagnostic Test: evaluation of cardiopulmonary parameters, gross motor development and hand grip strength

Interventions

  • Diagnostic testevaluation of cardiopulmonary parameters, gross motor development and hand grip strength

    Gross motor development was evaluated with Gross Motor Function Measure (GMFM-88). Hand grip strength was measured with the Baseline Pneumatic Bulb Dynamometer. Cardiopulmonary parameters values was evaluated with echocardiography.

06

What researchers measure

Primary outcomes

  1. Gross Motor Function Measure-88

    Gross motor development of the participants was evaluated with the Gross Motor Function Measure-88 questionnaire. The value as a percentage was obtained as a result of the survey. Gross Motor Function Measure-88 consists of 5 sections that include the evaluation of Lying \& Rolling, Sitting, Crawling \& Kneeling, Standing, Walking, Running \& Jumping activities. Each item in the sections consists of a 4-point scale. Scores for each section are summed and divided by 5.The maximum score on the scale is 100. A high score indicates good gross motor development. 0 = does not initiate 1. = initiates 2. = partially completes 3. = completes

    Time frame: october 2020- june 2021

  2. Bulb Dynamometer

    Hand grip strength was measured with a Baseline Pneumatic Bulb Dynamometer (Fabrication Enterprises INC, Elmsford, NY USA). With a bulb dynamometer, the spherical grip force is measured using a rubber balloon tip. The bulb dynamometer has 3 removable sizes. The values measured on the manometer are recorded in kPa. The measurement is repeated 3 times and the highest value is taken.

    Time frame: october 2020- june 2021

  3. Left ventricular ejection fraction (EF)

    Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist. It is obtained by dividing the difference in left ventricular volume at end-diastolic and end-systolic by the end-diastolic left ventricular volume. Left ventricular ejection fraction (EF) indicate the systolic function of the left ventricle. Ejection fraction value show as a percentage (%). The ejection fraction normal value is between 50 percent and 70 percent.

    Time frame: october 2020- june 2021

  4. Interventricular septum wall thickness (IVS)

    Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist. It is important in the risk classification potential of left ventricular systolic function. Its value is show as millimeters (mm).

    Time frame: october 2020- june 2021

  5. Left ventricular end-diastolic diameter (LVDd)

    Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist. It is important in the risk classification potential of left ventricular systolic function. Its value is show as millimeters (mm).

    Time frame: october 2020- june 2021

  6. Fractional shortening (FS)

    Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist. Fractional shortening evaluates left ventricular systolic function. Fractional shortening value show as a percentage (%). The value of normal fractional shortening in children is between 28-44%.

    Time frame: october 2020- june 2021

  7. Wang Respiratory Score

    The Wang respiratory score assesses respiratory frequency, wheezing, retraction, and general condition. parameters are scored between 0-3 and summed. A higher score indicates that the situation is getting severe.

    Time frame: october 2020- june 2021

07

Study locations

1 site
  • Atılım University
    Ankara, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05191654
Lead sponsor
Atılım University
Responsible party
Tuğba Şanlı (Principal Investigator, Atılım University) — Principal investigator
First posted
Jan 13, 2022
Start date
Oct 1, 2020
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Last update
Jan 13, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion